26474-1-AP

antibody from Proteintech Group

Targeting: SPC25 AD024, MGC22228, SPBC25

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

26474-1-AP

Provider

Proteintech Group

Product name

SPC25 antibody

Antibody type

Polyclonal

Description

SPC25 antibody (Cat. #26474-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Integrating Functional Genomic Screens and Multi-Omics Data to Construct a Prognostic Model for Lung Adenocarcinoma and Validating SPC25.

Zhang Y, Tan H, Jiang D
Cancers 2025 Nov 29;17(23)

---

TFDP1 activates SPC25-mediated glutamine metabolism to repress anti-tumor immunity of NK cells in lung adenocarcinoma.

Huang B, Chen K, Huang M, Yin Z, He W, Peng X, Wu G, Ding J, Peng C, Wu X
Expert review of clinical immunology 2025 Aug;21(8):1171-1181

---

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25.

Zhang W, Yu L, Xu C, Tang T, Cao J, Chen L, Pang X, Ren W
Cell biology international 2024 Sep;48(9):1285-1300

---

CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.

Fukuizumi A, Noro R, Seike M, Miyanaga A, Minegishi Y, Omori M, Hirao M, Matsuda K, Kunugi S, Nishiwaki K, Morimoto M, Motohashi H, Ohwada H, Usuda J, Gemma A
JTO clinical and research reports 2021 Nov;2(11):100232

---

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma.

Zhang B, Zhou Q, Xie Q, Lin X, Miao W, Wei Z, Zheng T, Pang Z, Liu H, Chen X
Aging 2020 Dec 19;13(2):2803-2821